Cancer cell-derived extracellular vesicles activate hepatic stellate cells in colorectal cancer

References

• Zhao S, Mi Y, Zheng B, et al. Highly-metastatic colorectal cancer cell released miR-181a-5p-rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment. J Extracell Vesicles. 2022;11(1):e12186. PubMed PMID: 35041299; PubMed Central PMCID: PMC8765330. doi: 10.1002/jev2.12186
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality Worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–249. Epub 20210204. PubMed PMID: 33538338. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Chen J, Zheng Y, Wang H, et al. Cause of death among patients with colorectal cancer: a population-based study in the United States. Aging. 2020;12(22):22927–22948. doi: 10.18632/aging.104022
   PubMedGoogle Scholar
• Peinado H, Zhang H, Matei IR, et al. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 2017;17(5):302–317. Epub 20170317. PubMed PMID: 28303905. doi: 10.1038/nrc.2017.6
   PubMed Web of Science ®Google Scholar
• Bhome R, Del Vecchio F, Lee GH, et al. Exosomal microRnas (exomiRs): Small molecules with a big role in cancer. Cancer Lett. Epub 20180207. PubMed PMID: 29425686: PubMed Central PMCID: PMC5831981 2018;420:228–235. doi: 10.1016/j.canlet.2018.02.002
   PubMed Web of Science ®Google Scholar
• Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255–289. Epub 20140821. PubMed PMID: 25288114. doi: 10.1146/annurev-cellbio-101512-122326
   PubMed Web of Science ®Google Scholar
• Doyle LM, Wang MZ. Overview of extracellular vesicles, their Origin, Composition, Purpose, and methods for Exosome Isolation and analysis. Cells. 2019;8(7). Epub 20190715. PubMed PMID: 31311206; PubMed Central PMCID: PMC6678302. doi: 10.3390/cells8070727
   Web of Science ®Google Scholar
• Winter J, Jung S, Keller S, et al. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009;11(3):228–234. PubMed PMID: 19255566. doi: 10.1038/ncb0309-228 .
   PubMed Web of Science ®Google Scholar
• Fabbri M, Paone A, Calore F, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A. 2012;109(31):E2110–6. Epub 20120702. PubMed PMID: 22753494; PubMed Central PMCID: PMC3412003. doi: 10.1073/pnas.1209414109
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRnas and microRnas is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–659. Epub 20070507. PubMed PMID: 17486113. doi: 10.1038/ncb1596.
   PubMed Web of Science ®Google Scholar
• Fujita T, Narumiya S Roles of hepatic stellate cells in liver inflammation: a new perspective. Inflamm Regen. 2016;36(1):1. Epub 20160425 PubMed PMID: 29259674; PubMed Central PMCID: PMC5721720. doi: 10.1186/s41232-016-0005-6
   PubMedGoogle Scholar
• Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25(2):195–206. PubMed PMID: 21497738; PubMed Central PMCID: PMC3079877. doi: 10.1016/j.bpg.2011.02.005
   Google Scholar
• Eveno C, Hainaud P, Rampanou A, et al. Proof of prometastatic niche induction by hepatic stellate cells. J Surg Res. 2015;194(2):496–504. Epub 20141110. PubMed PMID: 25528682. doi: 10.1016/j.jss.2014.11.005
   PubMed Web of Science ®Google Scholar
• Gondaliya P, Sayyed AA, Driscoll J, et al. Extracellular vesicle RNA signaling in the liver tumor microenvironment. Cancer Lett [Epub 20230208. PubMed PMID: 36758739; PubMed Central PMCID: PMC9992346]. 2023;558:216089. doi: 10.1016/j.canlet.2023.216089
   PubMed Web of Science ®Google Scholar
• Zhao S, Sun H, Jiang W, et al. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition. Mol Cancer. 2017;16(1):12. Epub 20170117. PubMed PMID: 28095858; PubMed Central PMCID: PMC5240405. doi: 10.1186/s12943-017-0585-z .
   PubMedGoogle Scholar
• Paget S. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. Lancet. 1889;133(3421):571–573. doi: 10.1016/S0140-6736(00)49915-0
   Google Scholar
• Valderrama-Treviño AI, Barrera-Mera B, Ceballos-Villalva JC, et al. Hepatic metastasis from colorectal cancer. Euroasian J Hepatogastroenterol. 2017;7(2):166–175. Epub 20170929. PubMed PMID: 29201802; PubMed Central PMCID: PMC5670263. doi: 10.5005/jp-journals-10018-1241
   PubMedGoogle Scholar
• Zeng Z, Li Y, Pan Y, et al. Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat Commun. 2018;9(1):5395. Epub 20181219. PubMed PMID: 30568162; PubMed Central PMCID: PMC6300604. doi: 10.1038/s41467-018-07810-w .
   PubMed Web of Science ®Google Scholar
• Tian F, Wang P, Lin D, et al. Exosome-delivered miR-221/222 exacerbates tumor liver metastasis by targeting SPINT1 in colorectal cancer. Cancer Sci. 2021;112(9):3744–3755. Epub 20210707. PubMed PMID: 34125460; PubMed Central PMCID: PMC8409403. doi: 10.1111/cas.15028
   PubMed Web of Science ®Google Scholar
• Xi Y, Nakajima G, Gavin E, et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA. 2007;13(10):1668–1674. Epub 20070813. PubMed PMID: 17698639; PubMed Central PMCID: PMC1986820. doi: 10.1261/rna.642907.
   PubMed Web of Science ®Google Scholar
• El-Hefnawy T, Raja S, Kelly L, et al. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem. 2004;50(3):564–573. Epub 20040112. PubMed PMID: 14718398. doi: 10.1373/clinchem.2003.028506
   PubMed Web of Science ®Google Scholar
• Rodríguez M, Silva J, López-Alfonso A, et al. Different exosome cargo from plasma/bronchoalveolar lavage in non-small-cell lung cancer. Genes Chromosomes Cancer. 2014;53(9):713–724. Epub 20140425. PubMed PMID: 24764226. doi: 10.1002/gcc.22181.
   PubMed Web of Science ®Google Scholar
• Indrieri A, Carrella S, Carotenuto P, et al. The Pervasive role of the miR-181 family in development, Neurodegeneration, and cancer. Int J Mol Sci. 2020;21(6): Epub 20200318. PubMed PMID: 32197476; PubMed Central PMCID: PMC7139714. doi: 10.3390/ijms21062092
   PubMed Web of Science ®Google Scholar
• Nishimura J, Handa R, Yamamoto H, et al. microRNA-181a is associated with poor prognosis of colorectal cancer. Oncol Rep. 2012;28(6):2221–2226. Epub 20120926. PubMed PMID: 23023298. doi: 10.3892/or.2012.2059
   PubMed Web of Science ®Google Scholar
• Ji D, Chen Z, Li M, et al. MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1. Mol Cancer [Epub 20140423. PubMed PMID: 24755295; PubMed Central PMCID: PMC4021214]. 2014;13:86. doi: 10.1186/1476-4598-13-86
   PubMed Web of Science ®Google Scholar
• Sun W, Wang X, Li J, et al. MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway. Cell Death Dis. 2018;9(4):438. Epub 20180401. PubMed PMID: 29739921; PubMed Central PMCID: PMC5941226. doi: 10.1038/s41419-018-0490-4.
   PubMedGoogle Scholar
• Gonzalez H, Hagerling C, Werb Z Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018;32(19–20):1267–1284. PubMed PMID: 30275043; PubMed Central PMCID: PMC6169832. doi: 10.1101/gad.314617.118
   PubMed Web of Science ®Google Scholar
• Bhome R, Bullock MD, Al Saihati HA, et al. A top-down view of the tumor microenvironment: structure, cells and signaling. Front Cell Dev Biol. 2015;3:33. [Epub 20150529. PubMed PMID: 26075202; PubMed Central PMCID: PMC4448519]. doi: 10.3389/fcell.2015.00033
   PubMed Web of Science ®Google Scholar
• Toyoshima Y, Kitamura H, Xiang H, et al. IL6 Modulates the immune Status of the tumor microenvironment to Facilitate metastatic Colonization of colorectal cancer cells. Cancer Immunol Res. 2019;7(12):1944–1957. Epub 20190925. PubMed PMID: 31554639. doi: 10.1158/2326-6066.CIR-18-0766
   PubMed Web of Science ®Google Scholar
• Kang N, Gores GJ, Shah VH. Hepatic stellate cells: partners in crime for liver metastases? Hepatology. 2011;54(2):707–713. PubMed PMID: 21520207; PubMed Central PMCID: PMC3145026. doi: 10.1002/hep.24384
   PubMed Web of Science ®Google Scholar
• Myojin Y, Hikita H, Sugiyama M, et al. Hepatic stellate cells in hepatocellular carcinoma promote tumor growth via growth Differentiation factor 15 Production. Gastroenterology. 2021;160(5):1741–54.e16. Epub 20201217. PubMed PMID: 33346004. doi: 10.1053/j.gastro.2020.12.015.
   PubMed Web of Science ®Google Scholar
• Correia AL, Guimaraes JC, Auf der Maur P, et al. Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy. Nature. 2021;594(7864):566–571. doi: 10.1038/s41586-021-03614-z
   PubMed Web of Science ®Google Scholar
• Huang WH, Zhou MW, Zhu YF, et al. The role of hepatic stellate cells in promoting liver metastasis of colorectal carcinoma. Onco Targets Ther. 2019;12:7573–7580. [Epub 20190916. PubMed PMID: 31571908; PubMed Central PMCID: PMC6754330]. doi: 10.2147/OTT.S214409
   PubMed Web of Science ®Google Scholar
• Tan HX, Gong WZ, Zhou K, et al. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer. Cancer Biol Ther. 2020;21(3):258–268. Epub 20191211. PubMed PMID: 31825725; PubMed Central PMCID: PMC7012097. doi: 10.1080/15384047.2019.1685157
   PubMed Web of Science ®Google Scholar
• Ma J, Liu X, Chen H, et al. C-KIT-ERK1/2 signaling activated ELK1 and upregulated carcinoembryonic antigen expression to promote colorectal cancer progression. Cancer Sci. 2021;112(2):655–667. Epub 20201219. PubMed PMID: 33247506; PubMed Central PMCID: PMC7894012. doi: 10.1111/cas.14750.
   PubMed Web of Science ®Google Scholar
• Ranjan A, Iyer SV, Ward C, et al. MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma. Oncotarget. 2018;9(30):21429–21443. Epub 20180420. PubMed PMID: 29765550; PubMed Central PMCID: PMC5940416. doi: 10.18632/oncotarget.25117.
   PubMedGoogle Scholar
• Barry OP, Mullan B, Sheehan D, et al. Constitutive ERK1/2 activation in esophagogastric rib bone marrow micrometastatic cells is MEK-independent. J Biol Chem. 2001;276(18):15537–15546. Epub 20010131. PubMed PMID: 11297525. doi: 10.1074/jbc.M010847200
   PubMed Web of Science ®Google Scholar
• Mizrahi JD, Surana R, Valle JW, et al. Pancreatic cancer. Lancet. 2020;395(10242):2008–2020. PubMed PMID: 32593337. doi: 10.1016/S0140-6736(20)30974-0
   PubMed Web of Science ®Google Scholar
• Walter FM, Mills K, Mendonça SC, et al. Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study. Lancet Gastroenterol Hepatol. 2016;1(4):298–306. Epub 20161004. PubMed PMID: 28404200; PubMed Central PMCID: PMC6358142. doi: 10.1016/S2468-1253(16)30079-6
   PubMed Web of Science ®Google Scholar
• Lyratzopoulos G, Saunders CL, Abel GA, et al. The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers. Br J Cancer. 2015;112(Suppl 1):S35–40. Epub 20150331. PubMed PMID: 25734380; PubMed Central PMCID: PMC4385974. doi: 10.1038/bjc.2015.40.
   PubMedGoogle Scholar
• Tomasello G, Ghidini M, Ghidini A, et al. Total neoadjuvant therapy for initially inoperable pancreatic cancer: A systematic review of phase 2-3 studies. Radiother Oncol [Epub 20210910. PubMed PMID: 34509562]. 2021;164:13–19. doi: 10.1016/j.radonc.2021.09.001
   PubMed Web of Science ®Google Scholar
• Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523(7559):177–182. Epub 20150624. PubMed PMID: 26106858; PubMed Central PMCID: PMC4825698. doi: 10.1038/nature14581.
   PubMed Web of Science ®Google Scholar
• Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17(6):816–826. Epub 20150518. PubMed PMID: 25985394; PubMed Central PMCID: PMC5769922. doi: 10.1038/ncb3169
   PubMed Web of Science ®Google Scholar
• Wang D, Wang R, Huang A, et al. Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma. Oncol Rep. 2018;40(5):2628–2636. Epub 20180912. PubMed PMID: 30226561; PubMed Central PMCID: PMC6151891. doi: 10.3892/or.2018.6703.
   PubMed Web of Science ®Google Scholar
• Gordon-Weeks AN, Lim SY, Yuzhalin AE, et al. Macrophage migration inhibitory factor: a key cytokine and therapeutic target in colon cancer. Cytokine Growth Factor Rev. 2015;26(4):451–461. Epub 20150407. PubMed PMID: 25882738. doi: 10.1016/j.cytogfr.2015.03.002
   PubMed Web of Science ®Google Scholar
• Subbannayya T, Leal-Rojas P, Barbhuiya MA, et al. Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer. BMC Cancer. 2015;15:843. Epub 20151104. PubMed PMID: 26530123; PubMed Central PMCID: PMC4632274. doi: 10.1186/s12885-015-1855-z
   PubMed Web of Science ®Google Scholar
• Cheng B, Wang Q, Song Y, et al. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo. Sci Rep. 2020;10(1):6741. Epub 20200421. PubMed PMID: 32317702; PubMed Central PMCID: PMC7174354. doi: 10.1038/s41598-020-63778-y.
   PubMed Web of Science ®Google Scholar
• Xie Z, Gao Y, Ho C, et al. Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment. Gut. 2022;71(3):568–579. Epub 20210407. PubMed PMID: 33827783. doi: 10.1136/gutjnl-2020-323014.
   PubMed Web of Science ®Google Scholar
• Yu Z, Zhao S, Ren L, et al. Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation. Oncotarget. 2017;8(38):63461–63483. Epub 20170628. PubMed PMID: 28969005; PubMed Central PMCID: PMC5609937. doi: 10.18632/oncotarget.18831.
   PubMedGoogle Scholar
• Liu DSK, Upton FM, Rees E, et al. Size-Exclusion Chromatography as a technique for the Investigation of novel extracellular vesicles in cancer. Cancers (Basel). 2020;12(11): Epub 20201027. PubMed PMID: 33121160; PubMed Central PMCID: PMC7693800. doi: 10.3390/cancers12113156
   Web of Science ®Google Scholar
• Unal B, Ozcan F, Tuzcu H, et al. Inhibition of neutral sphingomyelinase decreases elevated levels of nitrative and oxidative stress markers in liver ischemia-reperfusion injury. Epub 20160324. PubMed PMID: 27077455; PubMed Central PMCID: PMC6837382 Redox Rep. 2017;22(4):147–159. doi: 10.1080/13510002.2016.1162431
   PubMed Web of Science ®Google Scholar
• Vuckovic S, Vandyke K, Rickards DA, et al. The cationic small molecule GW4869 is cytotoxic to high phosphatidylserine-expressing myeloma cells. Br J Haematol. 2017;177(3):423–440. Epub 20170217. PubMed PMID: 28211573. doi: 10.1111/bjh.14561.
   PubMed Web of Science ®Google Scholar
• Bobrie A, Krumeich S, Reyal F, et al. Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res. 2012;72(19):4920–4930. Epub 20120803. PubMed PMID: 22865453. doi: 10.1158/0008-5472.CAN-12-0925
   PubMed Web of Science ®Google Scholar
• Leibovitz A, Stinson JC, McCombs WB, et al. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 1976;36(12):4562–4569. PubMed PMID: 1000501.
   PubMed Web of Science ®Google Scholar
• Thuringer D, Berthenet K, Cronier L, et al. Primary tumor- and metastasis-derived colon cancer cells differently modulate connexin expression and function in human capillary endothelial cells. Oncotarget. 2015;6(30):28800–28815. PubMed PMID: 26320187; PubMed Central PMCID: PMC4745693. doi: 10.18632/oncotarget.4894.
   PubMedGoogle Scholar
• Kamerkar S, LeBleu VS, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498–503. Epub 20170607. PubMed PMID: 28607485; PubMed Central PMCID: PMC5538883. doi: 10.1038/nature22341.
   PubMed Web of Science ®Google Scholar